Incidence of Inborn Errors of Metabolism in British Columbia, 1969–1996
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Objective.: To determine how many children with specific types of inborn errors of metabolism are born each year in British Columbia, Canada. This population provides a relatively unique setting for collection of accurate and uniform incidence data because the diagnoses are all made through one laboratory in a population with universal access to government-funded medical care. Methodology.: We used the records of the Biochemical Diseases Laboratory, Children's Hospital, Vancouver (the central referral point for all metabolic diagnoses in British Columbia) to identify all patients diagnosed with the metabolic diseases defined below. We obtained incidence figures by including only the children diagnosed with the diseases covered in this article who were confirmed as having been born within the province for the years 1969 to 1996. The diseases covered were diseases of amino acids, organic acids, the urea cycle, galactosemia, primary lactic acidoses, glycogen storage diseases, lysosomal storage diseases, and diseases involving specifically peroxisomal and mitochondrial respiratory chain dysfunction. Because the technology needed for diagnosis of specific disease groups was in place at different times our data for the different disease groups correspond to different time frames. We have also adjusted the time frames used to allow for the likelihood that some diseases may not come to medical attention for some time after birth. For instance the incidence of amino acid diseases was assessed throughout the whole of this time frame but the incidence of peroxisomal diseases was restricted to 1984 to 1996 because this was the time frame during which the technology needed for diagnosis was in place and reliable. Most disease group statistics included at least 400 000 births. Results.: The overall minimum incidence of the metabolic diseases surveyed in children born in British Columbia is ∼40 cases per 100 000 live births. This includes phenylketonuria (PKU) and galactosemia which are detected by a newborn screening program. Metabolic diseases, which were not screened for at birth, ie, those with PKU and galactosemia subtracted from the total, have a minimal incidence of ∼30 cases per 100 000 live births. This diagnostic dilemma group would present to pediatricians for diagnosis. Not all metabolic diseases have been surveyed and our data are restricted to the following metabolic disease groups. Approximately 24 children per 100 000 births (∼60% of the total disease groups surveyed) have a disease involving amino acids (including PKU), organic acids, primary lactic acidosis, galactosemia, or a urea cycle disease. These children all have metabolic diseases involving small molecules. Approximately 2.3 children per 100 000 births (∼5%) have some form of glycogen storage disease. Approximately 8 per 100 000 births (20%) have a lysosomal storage disease; ∼3 per 100 000 births (7%–8%) have a respiratory chain-based, mitochondrial disease and ∼3 to 4 per 100 000 (7%–8%) of births have a peroxisomal disease. The diseases involving subcellular organelles represent approximately half of the diagnostic dilemma group. The incidence of each of the specific diseases diagnosed, including apparently rare diseases such as nonketotic hyperglycinemia, is to be found in the text. The metabolic diseases reported in this survey represent over 10% of the total number of single gene disorders in our population. Conclusions.: Our data provide a good estimate of metabolic disease incidence, for the disease groups surveyed, in a predominantly Caucasian population. Incidence data for metabolic diseases are hard to collect because in very few centers are diagnoses centralized for a population with uniform access to modern health care and this has been the case for our population during the course of the study. We foresee a need for accurate information on the incidence of metabolic diseases as a guide to how to provide diagnostic and therapeutic services for metabolic diseases and the figures should help in assessing such needs in similar populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic disorders in children and young adults: a population study.
Baird, P. A., Anderson, T., Newcombe, H. B., & Lowry, R. B. (1988) · Europe PMC (PubMed Central) · Cited by 402
Self-citationRespiratory Chain Encephalomyopathies: A Diagnostic Classification
Walker, U. A., Collins, S., & Byrne, E. (1996) · European Neurology · doi:10.1159/000117269 · Cited by 174
An update on the frequency of mucopolysaccharide syndromes in British Columbia
Lowry, R. B., Applegarth, D. A., Toone, J. R., MacDonald, E., & Thunem, N. Y. (1990) · Human Genetics · doi:10.1007/bf00206770 · Cited by 138
Self-citationMetabolic Studies of a Family with Massive Formiminoglutamic Aciduria
Perry, T. L., Applegarth, D. A., EVANS, M. E., Hansen, S., & Jellum, E. (1975) · Pediatric Research · doi:10.1203/00006450-197503000-00001 · Cited by 43
Self-citationOrganelle Diseases: Clinical Features, Diagnosis, Pathogenesis, and Management
Clancy, J. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-780a-odcfdp · Cited by 31
Pike, M. G., Applegarth, D. A., Dunn, H. G., Bamforth, S. J., Tingle, A. J., Wood, B. J., Dimmick, J. E., Harris, H., Chantler, J. K., & Hall, J. G. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81651-8 · Cited by 27
Self-citationAn improved method for quantification of very long chain fatty acids in plasma
Vallance, H. D., & Applegarth, D. A. (1994) · Clinical Biochemistry · doi:10.1016/0009-9120(94)90053-1 · Cited by 25
Self-citationJuvenile galactosialidosis in a white male: A new variant
Chitayat, D. A., Applegarth, D. A., Lewis, J., Dimmick, J. E., McCormick, A. Q., Hall, J. G., Opitz, J. M., & Reynolds, J. F. (1988) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320310423 · Cited by 15
Self-citationChoy, F. Y. M., Wei, C., Applegarth, D. A., & McGillivray, B. C. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320510216 · Cited by 14
Self-citationSturman, J. A., & Applegarth, D. A. (2003) · Amino Acids · doi:10.1385/0-89603-077-6:1 · Cited by 8
Self-citation
Cited by
Metabolomics for Investigating Physiological and Pathophysiological Processes
Wishart, D. S. (2019) · Physiological Reviews · doi:10.1152/physrev.00035.2018 · Cited by 1,212
Epidemiology of mucopolysaccharidoses
Khan, S. A., Peracha, H., Ballhausen, D., Wiesbauer, A., Rohrbach, M., Gautschi, M., Mason, R. W., Giugliani, R., Suzuki, Y., Orii, K. E., et al. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.05.016 · Cited by 1,094
Pastores, G. M. (2012) · Swaiman's Pediatric Neurology · doi:10.1016/b978-1-4377-0435-8.00036-6 · Cited by 633
Minimum birth prevalence of mitochondrial respiratory chain disorders in children
Skladal, D. (2003) · Brain · doi:10.1093/brain/awg170 · Cited by 487
Overview of the mucopolysaccharidoses
Muenzer, J. (2011) · Rheumatology · doi:10.1093/rheumatology/ker394 · Cited by 486
Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients With Mitochondrial Disease
Scaglia, F., Towbin, J. A., Craigen, W. J., Belmont, J. W., Smith, E. O., Neish, S. R., Ware, S. M., Hunter, J. V., Fernbach, S. D., Vladutiu, G. D., et al. (2004) · Pediatrics · doi:10.1542/peds.2004-0718 · Cited by 466
Sanfilippo syndrome: A mini‐review
Valstar, M. J., Ruijter, G. J. G., van Diggelen, O. P., Poorthuis, B. J., & Wijburg, F. A. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0838-5 · Cited by 396
International Morquio A Registry: Clinical manifestation and natural course of Morquio A disease
Montaño, A. M., Tomatsu, S., Gottesman, G. S., Smith, M., & Orii, T. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0529-7 · Cited by 359
Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome)
Martin, R., Beck, M., Eng, C., Giugliani, R., Harmatz, P., Muñoz, V., & Muenzer, J. (2008) · Pediatrics · doi:10.1542/peds.2007-1350 · Cited by 314
Valayannopoulos, V., Nicely, H., Harmatz, P., & Turbeville, S. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-5 · Cited by 298
Glycogen storage diseases: New perspectives
Özen, H. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i18.2541 · Cited by 287
Mitochondrial disorders: prevalence, myths and advances
Thorburn, D. R. (2004) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000031098.41409.55 · Cited by 258
“While this ¢gure is clearly still likely to be an underestimate, it is comparable to the only two previous estimates of childhood-onset OXPHOS disorders of 3.2/100 000 (95% CI 1.7 5.5) in British Columbia (Applegarth et al 2000) and 8.9/100 000 births (95% CI 5.3 14.0) in western Sweden (Darin et al 2001), both studie…”
ResultInfluentialThe incidence of inherited metabolic disorders in the West Midlands, UK
Sanderson, S., Green, A., Preece, M. A., & Burton, H. (2006) · Archives of Disease in Childhood · doi:10.1136/adc.2005.091637 · Cited by 253
Matsa, E., Ahrens, J. H., & Wu, J. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00036.2015 · Cited by 105
“Familial metabolic disorders, also known as inborn errors of metabolism (IEMs), represent more than 15% of monogenic disorders (8).”
BackgroundAdeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration
Lau, A. A., & Hemsley, K. M. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1562-0 · Cited by 9
Metadata
- Authors
- Applegarth, D. A., Toone, J. R., & Lowry, R. A. R. B.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2000-01-01
- Volume
- 105
- Issue
- 1
- Pages
- e10-e10
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2050180123
- Cited by
- 407
- References
- 10
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.